UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non‐invasive assessments for liver fibrosis: The crystal ball we long for

Journal of gastroenterology and hepatology, 2018-05, Vol.33 (5), p.1009-1015

Wong, Grace Lai‐Hung

2018

Volltextzugriff (PDF)

Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2022-08, Vol.76 (2), p.469-482

2022

Volltextzugriff (PDF)

Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1750-1765

2021

Volltextzugriff (PDF)

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

Alimentary pharmacology & therapeutics, 2019-11, Vol.50 (9), p.1037-1048

2019

Volltextzugriff (PDF)

Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong

Hepatology research, 2020-09, Vol.50 (9), p.1024-1031

2020

Volltextzugriff (PDF)

Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2022-11, Vol.76 (5), p.1409-1422

2022

Volltextzugriff (PDF)

Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness

Hepatology (Baltimore, Md.), 2019-09, Vol.70 (3), p.971-981

2019

Volltextzugriff (PDF)

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver‐Related Cirrhosis

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2238-2250

2021

Volltextzugriff (PDF)

Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis

Journal of gastroenterology and hepatology, 2021-03, Vol.36 (3), p.543-550

2021

Volltextzugriff (PDF)

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue

Liver international, 2018-03, Vol.38 (3), p.503-514

2018

Volltextzugriff (PDF)

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance

Alimentary pharmacology & therapeutics, 2024-05, Vol.59 (10), p.1223-1235

2024

Volltextzugriff (PDF)

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss

Alimentary pharmacology & therapeutics, 2021-01, Vol.53 (2), p.321-331

2021

Volltextzugriff (PDF)

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.814-823

2023

Volltextzugriff (PDF)

Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD‐related liver fibrosis

Liver international, 2024-03, Vol.44 (3), p.749-759

2024

Volltextzugriff (PDF)

Repeating measurements by transient elastography in non‐alcoholic fatty liver disease patients with high liver stiffness

Journal of gastroenterology and hepatology, 2019-01, Vol.34 (1), p.241-248

2019

Volltextzugriff (PDF)

Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study

Journal of gastroenterology and hepatology, 2017-02, Vol.32 (2), p.506-514

2017

Volltextzugriff (PDF)

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B

Journal of gastroenterology and hepatology, 2020-09, Vol.35 (9), p.1610-1618

2020

Volltextzugriff (PDF)

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory‐wide cohort study

Journal of gastroenterology and hepatology, 2018-04, Vol.33 (4), p.934-941

2018

Volltextzugriff (PDF)

Unmet need in chronic hepatitis B management

Clinical and Molecular Hepatology, 2019, 25(2), , pp.172-180

2019

Volltextzugriff (PDF)

Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

Journal of gastroenterology and hepatology, 2017-06, Vol.32 (6), p.1230-1233

2017

Volltextzugriff (PDF)

Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy

Gut, 2020-06, Vol.69 (6), p.1116-1126

2020

Volltextzugriff (PDF)

Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (5), p.869-877

2022

Volltextzugriff (PDF)

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan

Journal of hepatology, 2012-04, Vol.56 (4), p.833-839

2012

Volltextzugriff (PDF)

A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma

Clinical gastroenterology and hepatology, 2024-03, Vol.22 (3), p.602-610.e7

2024

Volltextzugriff (PDF)

Transient elastography: Kill two birds with one stone?

World journal of hepatology, 2013-05, Vol.5 (5), p.264-274

Wong, Grace Lai-Hung

2013

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Connect here FIRST to enable access

ThemaCirrhosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(66)

Sprache

Englisch
(64)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Non‐invasive assessments for liver fibrosis: The crystal ball we long for

Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease

Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong

Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver‐Related Cirrhosis

Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection

Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD‐related liver fibrosis

Repeating measurements by transient elastography in non‐alcoholic fatty liver disease patients with high liver stiffness

Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory‐wide cohort study

Unmet need in chronic hepatitis B management

Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy

Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan

A Liver Stiffness–Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma

Transient elastography: Kill two birds with one stone?

Aktive Filter

Suchergebnisse filtern